Published in Arch Surg on April 01, 1998
Why cancer and inflammation? Yale J Biol Med (2006) 2.13
The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J (2015) 1.69
TNF-alpha increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes. Br J Cancer (2003) 1.10
Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism. Cancer Res (2008) 1.10
Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone. Br J Cancer (2004) 1.08
Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth? Cancers (Basel) (2010) 1.04
A new hypothesis for the cancer mechanism. Cancer Metastasis Rev (2012) 1.03
Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection. Neurosurg Rev (2009) 0.96
Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers. Dig Dis Sci (2007) 0.89
Implications of post-pneumonectomy compensatory lung growth in pulmonary physiology and disease. Respir Res (2001) 0.89
Postoperative Complications following Nodal Dissection and Their Association with Melanoma Recurrence. ISRN Surg (2013) 0.84
B16F10 melanoma cell colonization of mouse lung is enhanced by partial pneumonectomy. Clin Exp Metastasis (2002) 0.84
The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy. Ann Surg (2006) 0.84
Effect of carbon dioxide pneumoperitoneum and wound closure technique on port site tumor implantation in a rat model. Surg Endosc (2005) 0.82
The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation. Cancer Microenviron (2011) 0.81
Intracranial Undifferentiated Sarcoma Arising from a Low-Grade Glioma: A Case Report and Literature Review. J Korean Neurosurg Soc (2015) 0.81
Assessment of the tumourigenic and metastatic properties of SK-MEL28 melanoma cells surviving electrochemotherapy with bleomycin. Radiol Oncol (2012) 0.80
Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model. Neoplasia (2014) 0.80
Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review. ISRN Vet Sci (2011) 0.79
Preoperative Computed Tomography to Predict and Stratify the Risk of Severe Pancreatic Fistula After Pancreatoduodenectomy. Medicine (Baltimore) (2015) 0.78
The influence of reactive oxygen species on the adhesion of pancreatic carcinoma cells to the peritoneum. Cell Adh Migr (2007) 0.78
Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3. BMC Cancer (2013) 0.77
Metastatic tumor dormancy in cutaneous melanoma: does surgery induce escape? Cancers (Basel) (2011) 0.77
Lymphadenectomy promotes tumor growth and cancer cell dissemination in the spontaneous RET mouse model of human uveal melanoma. Oncotarget (2015) 0.76
Cancer seeding contributes to intestinal anastomotic dehiscence. World J Surg Oncol (2013) 0.75
Effect of biopsy technique on the survival rate of malignant melanoma patients. Arch Plast Surg (2014) 0.75
Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesions. Springerplus (2015) 0.75
Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 3.54
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer (1993) 2.89
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med (1978) 2.69
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61
Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol (1993) 2.59
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med (2000) 2.19
[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. Ned Tijdschr Geneeskd (2008) 2.06
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum (1994) 2.04
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol (2007) 1.98
Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol (1995) 1.90
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
Proceedings: Treatment of minimal breast cancer. Cancer (1974) 1.78
Anorectal melanoma. Cancer (1981) 1.77
Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg (1996) 1.77
Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol (2012) 1.70
Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res (1994) 1.66
Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science (1966) 1.65
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol (2000) 1.62
HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha. Am J Physiol Cell Physiol (2001) 1.61
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev (2004) 1.60
Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol (2002) 1.54
Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.52
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Ann Oncol (2004) 1.52
Continuous leakage measurement during hyperthermic isolated limb perfusion. Ann Surg Oncol (2001) 1.49
Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg (1978) 1.49
Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum (1978) 1.44
Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors. Lab Invest (1994) 1.44
Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity. Clin Cancer Res (2000) 1.42
Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol (2003) 1.41
Predicting postoperative mortality after colorectal surgery: a novel clinical model. Colorectal Dis (2014) 1.41
T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg (1975) 1.40
[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. Ned Tijdschr Geneeskd (2005) 1.39
[Myositis as the first manifestation of an exacerbation of Crohn's disease]. Ned Tijdschr Geneeskd (2007) 1.39
Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg (1992) 1.38
Macrophage-induced neutrophil apoptosis. J Immunol (2000) 1.35
The current status of S-100B as a biomarker in melanoma. Eur J Surg Oncol (2012) 1.34
Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol (2006) 1.33
Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am J Physiol (1998) 1.32
Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol (2004) 1.31
Immunogenic properties of reticulum cell sarcomas of SJL/J mice. J Natl Cancer Inst (1970) 1.30
Diagnosis and management of giant intrasacral schwannoma. Cancer (1992) 1.28
Genetic predisposition to testicular germ-cell tumours. Lancet Oncol (2004) 1.28
Epiphyseal fractures in children treated for osteosarcoma of the femur with chemotherapy, tumourresection, and endoprosthesis: report of four fractures in two children. J Surg Oncol (1984) 1.28
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27
Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors. Ann Oncol (2009) 1.25
Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg (1995) 1.24
Limb salvage surgery for primary bone sarcoma of the lower extremities: long-term consequences of endoprosthetic reconstructions. Ann Surg Oncol (1998) 1.24
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.23
Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg (1985) 1.22
Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg (1994) 1.21
Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol (2006) 1.21
Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer (1993) 1.20
Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum (1983) 1.19
Detection of unknown occult primary tumors using positron emission tomography. Cancer (1998) 1.18
Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy. Br J Surg (1995) 1.17
Familial testicular cancer in a single-centre population. Eur J Cancer (1999) 1.17
Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg (1981) 1.16
Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol (2006) 1.15
External and internal hemipelvectomy for sarcomas of the pelvic girdle: consequences of limb-salvage treatment. Eur J Surg Oncol (1997) 1.15
Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol (2001) 1.13
Sexual functioning after treatment for testicular cancer--review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav (2001) 1.13
Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med (1996) 1.11
Chromosomal analysis and the classification of soft tissue sarcomas. Lab Invest (1989) 1.10
Immunologic reactivity in patients with primary operable breast cancer. Cancer (1978) 1.10
Macrophage phagocytosis of wound neutrophils. J Leukoc Biol (1999) 1.09
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. J Clin Oncol (1987) 1.08
Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg (1987) 1.07
Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages. Am J Physiol (1999) 1.06
Interleukin-6 activity in wounds. Am J Physiol (1994) 1.06
Is carcinoma of the gallbladder a curable lesion? Ann Surg (1982) 1.05
Soft tissue sarcoma--compliance with guidelines. Cancer (2001) 1.04
Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol (2006) 1.04
Macrophage activation by culture in an anoxic environment. J Immunol (1995) 1.03
Asymptomatic pseudotumours after metal-on-metal hip resurfacing show little change within one year. Bone Joint J (2013) 1.03
The effect of chemotherapy on the growing skeleton. Cancer Treat Rev (2000) 1.03
Pelvic exenteration for recurrent rectal cancer. Adv Surg (1996) 1.02
Osteosarcoma of the pelvis--oncological results of 40 patients registered by The Netherlands Committee on Bone Tumours. Eur J Surg Oncol (2000) 1.01
Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins. Eur J Surg Oncol (2009) 1.01
Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol (2008) 1.01
Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery (1981) 1.00
Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. Eur J Cancer (2004) 0.99
Pleural mesothelioma. Cancer (1976) 0.99
Clinico-pathological data and prognostic factors in completely resected AJCC stage I-III liposarcomas. Ann Surg Oncol (2000) 0.99
Current treatment for colorectal cancer metastatic to the liver. Eur J Surg Oncol (1999) 0.98
Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Eur J Surg Oncol (2003) 0.98
Repeated resection of recurrent pulmonary metastatic soft tissue sarcoma. Eur J Surg Oncol (1994) 0.97
Frozen section analysis of sentinel lymph nodes in melanoma patients. Cancer (2000) 0.97
Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg (1992) 0.97
Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg (1993) 0.97
Promotion of neutrophil chemotaxis through differential regulation of beta 1 and beta 2 integrins. J Immunol (1999) 0.96